Mila Bukova, Dominik Funken, Eva‐Doreen Pfister, Ulrich Baumann, Nicolas Richter, Florian F. W. Vondran, Christoph M. Happel, Harald Bertram – 20 April 2022 – This study aims to evaluate the long‐term efficacy and reintervention rate after primary percutaneous portal vein stent angioplasty for portal vein stenosis (PVS) in pediatric liver transplantation (LT) recipients. From 2004 to 2020, a total of 470 pediatric LTs were performed in our center. All cases were screened for interventional PVS treatment and analyzed retrospectively.

Zhewen Ren, Pomme I. H. G. Simons, Anke Wesselius, Coen D. A. Stehouwer, Martijn C. G. J. Brouwers – 19 April 2022

Wilson disease (WD; also known as hepatolenticular degeneration) was first described in 1912 by Kinnear Wilson as “progressive lenticular degeneration,” a familial, lethal neurological disease accompanied by chronic liver disease leading to cirrhosis.

Previous guidelines reviewing vascular disorders of the liver focused on thrombosis of large vessels, such as the portal vein (PV) and hepatic vein (HV)

Transjugular Intrahepatic Portosystemic Shunt (TIPS) has been in use for more than 20 years to treat the complications of portal hypertension and TIPS have been created in thousands of patients with liver disease worldwide.

This first Practice Guidance on Reproductive Health from AASLD is intended to be a comprehensive reference on adolescents and adults with chronic liver disease.

AASLD develops evidence-based practice guidelines and practice guidances which are updated regularly by a multi-disciplinary panel of experts, including hepatologists, and include recommendations of preferred approaches to the diagnostic, therapeutic, and preventive aspects of care. 

Li Chen, Jun Dong, Qingtao Meng, Zhiyin Song – 18 April 2022

Michael Cooper, Rahul G. Krishnan, Mamatha Bhat – 18 April 2022

Martín Uriel Vázquez‐Medina, Eira Cerda‐Reyes, Alberto Galeana‐Pavón, Carlos Enrique López‐Luna, Patty Marlen Ramírez‐Portillo, Gabriela Ibañez‐Cervantes, Julián Torres‐Vázquez, Cruz Vargas‐De‐León – 18 April 2022 – Patients with pre‐existing liver diseases are considered to have an increased risk of morbidity and mortality from any type of infection, including viruses.